RAB27A and neoplasm: Hypoxic conditions upregulate the expression of Rab27a in B cells and promote the release of CD19+ extracellular vesicles, which generate immunosuppressive adenosine from treated tumours through the CD39/CD73 pathway, ultimately impairing the function of CD8+ T cells.